← Back to Bills
HJRES 217118th CongressFailed / ExpiredHouse

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare Program; FY 2025 Hospice Wage Index and Payment Rate Update, Hospice Conditions of Participation Updates, and Hospice Quality Reporting Program Requirements".

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 16, 2024
Latest Action Date
Oct 29, 2024

Latest Action

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

This House Joint Resolution (HJRES 217) from the 118th Congress proposes congressional disapproval of a rule submitted by the Centers for Medicare & Medicaid Services (CMS). The rule concerns updates to the Medicare Program for Fiscal Year 2025, specifically addressing the Hospice Wage Index and Payment Rate Update, Hospice Conditions of Participation Updates, and Hospice Quality Reporting Program Requirements. The resolution seeks to nullify these CMS rule changes under the authority of chapter 8 of title 5, United States Code, which governs congressional review of federal regulations.

Bottom Line

HJRES 217 aims to reject CMS's FY 2025 hospice payment and quality reporting rule, but the resolution ultimately failed or expired without becoming law.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The resolution targets CMS's rule on hospice wage index, payment rates, conditions of participation, and quality reporting for FY 2025.
  • It uses the Congressional Review Act process to disapprove a federal agency rule.
  • The bill was referred to the House Committees on Ways and Means and Energy and Commerce for consideration.
Who Benefits?

['Hospice care providers potentially affected by payment rates and conditions of participation', 'CMS as the federal agency responsible for Medicare regulations', 'Medicare beneficiaries receiving hospice care']

Potential Concerns

['Implementation challenges if the disapproval affects hospice payment updates and quality reporting timelines', "Potential impacts on hospice providers' reimbursement and regulatory compliance", 'Oversight considerations regarding the balance of congressional authority and agency rulemaking']

Political Context

This resolution is part of the Congressional Review Act process allowing Congress to disapprove federal agency rules. It was introduced in the House and referred to relevant committees for review. The bill status indicates it failed or expired, meaning it did not advance to override the CMS rule. The policy area is health, focusing on Medicare hospice care regulations.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['If enacted, disapproval could delay or alter hospice payment updates, potentially affecting hospice care quality and availability.', 'Could set precedent for future congressional disapproval of CMS or other agency rules, influencing regulatory stability.', 'Hospice providers might face uncertainty in financial planning and compliance due to potential rule reversals.']

GovScope Watchdog Notes

The bill text is not provided, limiting detailed analysis of specific provisions. The resolution's failure or expiration status indicates it did not become law, which is important for understanding its current impact. Transparency about the rule's content and congressional deliberations would aid public understanding of the policy tradeoffs involved.

Passage Likelihood: LowConfidence: 85%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready